NOTICE OF ALLOWANCE - ISSUED
issued
on 24 Sep 2024
Last Applicant/ Owned by
One Johnson & Johnson Plaza
New Brunswick
NJ
08933
Serial Number
98382826 filed on 30th Jan 2024
Registration Number
N/A
Correspondent Address
Danielle Rivera
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
STRELZANTI
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic dise Read More
Classification Information
Class [005]
Pharmaceutical Products
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98382826
Mark Type
No Service/Collective Mark
Attorney Docket Number
No T45816US2
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 24th Sep 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 30th Jul 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 30th Jul 2024 | PUBLISHED FOR OPPOSITION |
| 10th Jul 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 24th Jun 2024 | ASSIGNED TO EXAMINER |
| 24th Jun 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 30th May 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 30th Jan 2024 | NEW APPLICATION ENTERED |